The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Drug targets for corona virus: A systematic review
Open accessAbstract
century. However, the lack of specific drugs to prevent/treat an attack is a major need at this current point of time. In this regard, we conducted a systematic review to identify major druggable targets in coronavirus (CoV). We searched PubMed and RCSB database with keywords HCoV, NCoV, corona virus, SERS-CoV, MERS-CoV, 2019-nCoV, crystal structure, X-ray crystallography structure, NMR structure, target, and drug target till Feb 3, 2020. The search identified seven major targets (spike protein, envelop protein, membrane protein, protease, nucleocapsid protein, hemagglutinin esterase, and helicase) for which drug design can be considered. There are other 16 nonstructural proteins (NSPs), which can also be considered from the drug design perspective. The major structural proteins and NSPs may serve an important role from drug design perspectives. However, the occurrence of frequent recombination events is a major deterrent factor toward the development of CoV-specific vaccines/drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
SARS and MERS: recent insights into emerging coronaviruses
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510
Structure, Function, and Evolution of Coronavirus Spike Proteins
Li, F. (2016) · Annual Review of Virology · doi:10.1146/annurev-virology-110615-042301 · Cited by 2,740
Coronavirus Infections—More Than Just the Common Cold
Paules, C. I., Marston, H. D., & Fauci, A. S. (2020) · JAMA · doi:10.1001/jama.2020.0757 · Cited by 2,136
Coronavirus envelope protein: current knowledge
Schoeman, D., & Fielding, B. C. (2019) · Virology Journal · doi:10.1186/s12985-019-1182-0 · Cited by 2,074
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Vincent, M. J., Bergeron, E., Benjannet, S., Erickson, B. R., Rollin, P. E., Ksiazek, T. G., Seidah, N. G., & Nichol, S. T. (2005) · Virology Journal · doi:10.1186/1743-422x-2-69 · Cited by 1,811
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B.-J., & Jiang, S. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2090 · Cited by 1,661
Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein
Belouzard, S., Millet, J. K., Licitra, B. N., & Whittaker, G. R. (2012) · Viruses · doi:10.3390/v4061011 · Cited by 1,368
Ding, Y., He, L., Zhang, Q., Huang, Z., Che, X., Hou, J., Wang, H., Shen, H., Qiu, L., Li, Z., et al. (2004) · The Journal of Pathology · doi:10.1002/path.1560 · Cited by 1,076
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry
Simmons, G., Gosalia, D. N., Rennekamp, A. J., Reeves, J. D., Diamond, S. L., & Bates, P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505577102 · Cited by 1,052
Yang, H., Yang, M., Ding, Y., Liu, Y., Lou, Z., Zhou, Z., Sun, L., Mo, L., Ye, S., Pang, H., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1835675100 · Cited by 990
The Coronavirus Nucleocapsid Is a Multifunctional Protein
McBride, R., Van Zyl, M., & Fielding, B. (2014) · Viruses · doi:10.3390/v6082991 · Cited by 942
Song, W., Gui, M., Wang, X., & Xiang, Y. (2018) · PLOS Pathogens · doi:10.1371/journal.ppat.1007236 · Cited by 834
Yuan, Y., Cao, D., Zhang, Y., Ma, J., Qi, J., Wang, Q., Lu, G., Wu, Y., Yan, J., Shi, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms15092 · Cited by 760
Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases
Yang, H., Xie, W., Xue, X., Yang, K., Ma, J., Liang, W., Zhao, Q., Zhou, Z., Pei, D., Ziebuhr, J., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030324 · Cited by 727
Inhibition of SARS-CoV 3CL protease by flavonoids
Jo, S., Kim, S., Shin, D. H., & Kim, M.-S. (2020) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2019.1690480 · Cited by 685
From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design
Hilgenfeld, R. (2014) · The FEBS Journal · doi:10.1111/febs.12936 · Cited by 660
Lim, J., Jeon, S., Shin, H.-Y., Kim, M. J., Seong, Y. M., Lee, W. J., Choe, K.-W., Kang, Y. M., Lee, B., & Park, S.-J. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e79 · Cited by 636
CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus
Jeffers, S. A., Tusell, S. M., Gillim-Ross, L., Hemmila, E. M., Achenbach, J. E., Babcock, G. J., Thomas, W. D., Thackray, L. B., Young, M. D., Mason, R. J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403812101 · Cited by 605
Pathology and Pathogenesis of Severe Acute Respiratory Syndrome
Gu, J., & Korteweg, C. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.061088 · Cited by 592
Gui, M., Song, W., Zhou, H., Xu, J., Chen, S., Xiang, Y., & Wang, X. (2017) · Cell Research · doi:10.1038/cr.2016.152 · Cited by 589
Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion
Walls, A. C., Xiong, X., Park, Y.-J., Tortorici, M. A., Snijder, J., Quispe, J., Cameroni, E., Gopal, R., Dai, M., Lanzavecchia, A., et al. (2019) · Cell · doi:10.1016/j.cell.2018.12.028 · Cited by 582
Barretto, N., Jukneliene, D., Ratia, K., Chen, Z., Mesecar, A. D., & Baker, S. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15189-15198.2005 · Cited by 582
The SARS coronavirus nucleocapsid protein – Forms and functions
Chang, C.-K., Hou, M.-H., Chang, C.-F., Hsiao, C.-D., & Huang, T.-H. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2013.12.009 · Cited by 529
A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
Xia, S., Yan, L., Xu, W., Agrawal, A. S., Algaissi, A., Tseng, C.-T. K., Wang, Q., Du, L., Tan, W., Wilson, I. A., et al. (2019) · Science Advances · doi:10.1126/sciadv.aav4580 · Cited by 501
Yang, Z.-Y., Huang, Y., Ganesh, L., Leung, K., Kong, W.-P., Schwartz, O., Subbarao, K., & Nabel, G. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5642-5650.2004 · Cited by 490
Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines
Liu, X., & Wang, X.-J. (2020) · Journal of Genetics and Genomics · doi:10.1016/j.jgg.2020.02.001 · Cited by 464
Ratia, K., Saikatendu, K. S., Santarsiero, B. D., Barretto, N., Baker, S. C., Stevens, R. C., & Mesecar, A. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510851103 · Cited by 414
Lindner, H. A., Fotouhi-Ardakani, N., Lytvyn, V., Lachance, P., Sulea, T., & Ménard, R. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15199-15208.2005 · Cited by 371
Bertram, S., Glowacka, I., Müller, M. A., Lavender, H., Gnirss, K., Nehlmeier, I., Niemeyer, D., He, Y., Simmons, G., Drosten, C., et al. (2011) · Journal of Virology · doi:10.1128/jvi.05300-11 · Cited by 329
Egloff, M.-P., Ferron, F., Campanacci, V., Longhi, S., Rancurel, C., Dutartre, H., Snijder, E. J., Gorbalenya, A. E., Cambillau, C., & Canard, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307877101 · Cited by 306
Zeng, Q., Langereis, M. A., van Vliet, A. L. W., Huizinga, E. G., & de Groot, R. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800502105 · Cited by 288
te Velthuis, A. J. W., van den Worm, S. H. E., & Snijder, E. J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr893 · Cited by 265
Mechanism of the Maturation Process of SARS-CoV 3CL Protease
Hsu, M.-F., Kuo, C.-J., Chang, K.-T., Chang, H.-C., Chou, C.-C., Ko, T.-P., Shr, H.-L., Chang, G.-G., Wang, A. H.-J., & Liang, P.-H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502577200 · Cited by 262
Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein
Nieto-Torres, J. L., DeDiego, M. L., Álvarez, E., Jiménez-Guardeño, J. M., Regla-Nava, J. A., Llorente, M., Kremer, L., Shuo, S., & Enjuanes, L. (2011) · Virology · doi:10.1016/j.virol.2011.03.029 · Cited by 262
Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors
Park, Y.-J., Walls, A. C., Wang, Z., Sauer, M. M., Li, W., Tortorici, M. A., Bosch, B.-J., DiMaio, F., & Veesler, D. (2019) · Nature Structural & Molecular Biology · doi:10.1038/s41594-019-0334-7 · Cited by 260
Báez-Santos, Y. M., Barraza, S. J., Wilson, M. W., Agius, M. P., Mielech, A. M., Davis, N. M., Baker, S. C., Larsen, S. D., & Mesecar, A. D. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401712t · Cited by 255
Characterization of the Coronavirus M Protein and Nucleocapsid Interaction in Infected Cells
Narayanan, K., Maeda, A., Maeda, J., & Makino, S. (2000) · Journal of Virology · doi:10.1128/jvi.74.17.8127-8134.2000 · Cited by 255
Structure and Inhibition of the SARS Coronavirus Envelope Protein Ion Channel
Pervushin, K., Tan, E., Parthasarathy, K., Lin, X., Jiang, F. L., Yu, D., Vararattanavech, A., Soong, T. W., Liu, D. X., & Torres, J. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000511 · Cited by 253
Prabakaran, P., Gan, J., Feng, Y., Zhu, Z., Choudhry, V., Xiao, X., Ji, X., & Dimitrov, D. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600697200 · Cited by 238
Membrane Binding Proteins of Coronaviruses
J Alsaadi, E. A., & Jones, I. M. (2019) · Future Virology · doi:10.2217/fvl-2018-0144 · Cited by 230
Coronavirus Nsp10, a Critical Co-factor for Activation of Multiple Replicative Enzymes
Bouvet, M., Lugari, A., Posthuma, C. C., Zevenhoven, J. C., Bernard, S., Betzi, S., Imbert, I., Canard, B., Guillemot, J.-C., Lécine, P., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.577353 · Cited by 227
Han, D. P., Penn-Nicholson, A., & Cho, M. W. (2006) · Virology · doi:10.1016/j.virol.2006.01.029 · Cited by 214
Coronavirus envelope (E) protein remains at the site of assembly
Venkatagopalan, P., Daskalova, S. M., Lopez, L. A., Dolezal, K. A., & Hogue, B. G. (2015) · Virology · doi:10.1016/j.virol.2015.02.005 · Cited by 210
A model of the ACE2 structure and function as a SARS-CoV receptor
Prabakaran, P., Xiao, X., & Dimitrov, D. S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.081 · Cited by 209
Jacobs, J., Grum-Tokars, V., Zhou, Y., Turlington, M., Saldanha, S. A., Chase, P., Eggler, A., Dawson, E. S., Baez-Santos, Y. M., Tomar, S., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301580n · Cited by 200
Mubarak, A., Alturaiki, W., & Hemida, M. G. (2019) · Journal of Immunology Research · doi:10.1155/2019/6491738 · Cited by 199
Wang, F., Chen, C., Tan, W., Yang, K., & Yang, H. (2016) · Scientific Reports · doi:10.1038/srep22677 · Cited by 189
Pathogenetic mechanisms of severe acute respiratory syndrome
Guo, Y., Korteweg, C., McNutt, M. A., & Gu, J. (2008) · Virus Research · doi:10.1016/j.virusres.2007.01.022 · Cited by 188
A Conserved Domain in the Coronavirus Membrane Protein Tail Is Important for Virus Assembly
Arndt, A. L., Larson, B. J., & Hogue, B. G. (2010) · Journal of Virology · doi:10.1128/jvi.01131-10 · Cited by 187
Drug Design Targeting the Main Protease, the Achilles Heel of Coronaviruses
Yang, H., Bartlam, M., & Rao, Z. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206779010369 · Cited by 185
Adedeji, A. O., Severson, W., Jonsson, C., Singh, K., Weiss, S. R., & Sarafianos, S. G. (2013) · Journal of Virology · doi:10.1128/jvi.00998-13 · Cited by 183
SAIF, L. J. (2004) · Revue Scientifique et Technique de l'OIE · doi:10.20506/rst.23.2.1513 · Cited by 177
Han, D. P., Lohani, M., & Cho, M. W. (2007) · Journal of Virology · doi:10.1128/jvi.00315-07 · Cited by 157
Kao, R. Y., Tsui, W. H. W., Lee, T. S. W., Tanner, J. A., Watt, R. M., Huang, J.-D., Hu, L., Chen, G., Chen, Z., Zhang, L., et al. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.07.013 · Cited by 156
Inhibition of SARS-CoV replication by siRNA
Wu, C., Huang, H.-W., Liu, C.-Y., Hong, C.-F., & Chan, Y.-L. (2004) · Antiviral Research · doi:10.1016/j.antiviral.2004.09.005 · Cited by 153
Ghosh, A. K., Takayama, J., Rao, K. V., Ratia, K. M., Chaudhuri, R., Mulhearn, D. C., Lee, H., Nichols, D. B., Baliji, S., Baker, S. C., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1004489 · Cited by 151
Lin, S.-Y., Liu, C., Chang, Y., Zhao, J., Perlman, S. M., & Hou, M. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500089r · Cited by 137
Understanding Helicases as a Means of Virus Control
Frick, D. N., & Lam, A. M. I. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206776361147 · Cited by 131
Stobart, C. C., Sexton, N. R., Munjal, H., Lu, X., Molland, K. L., Tomar, S., Mesecar, A. D., & Denison, M. R. (2013) · Journal of Virology · doi:10.1128/jvi.02050-13 · Cited by 127
Turlington, M., Chun, A. C., Tomar, S., Eggler, A. L., Grum-Tokars, V. L., Jacobs, J., Daniels, J. S., Dawson, E. S., Saldanha, A., Chase, P. S., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.08.112 · Cited by 125
Exceptional Flexibility in the Sequence Requirements for Coronavirus Small Envelope Protein Function
Kuo, L., Hurst, K. R., & Masters, P. S. (2006) · Journal of Virology · doi:10.1128/jvi.01577-06 · Cited by 118
Coronavirus Structural Proteins and Virus Assembly
Hogue, B. G., & Machamer, C. E. (2014) · ASM Press eBooks · doi:10.1128/9781555815790.ch12 · Cited by 114
Chang, C., Lo, S.-C., Wang, Y., & Hou, M. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.11.015 · Cited by 113
Hu, T., Zhang, Y. L., Li, L., Wang, K., Chen, S., Chen, J., Ding, J., Jiang, H., & Shen, X. (2009) · Virology · doi:10.1016/j.virol.2009.03.034 · Cited by 108
NTPase and 5′ to 3′ RNA Duplex-Unwinding Activities of the Hepatitis E Virus Helicase Domain
Karpe, Y. A., & Lole, K. S. (2010) · Journal of Virology · doi:10.1128/jvi.02130-09 · Cited by 105
Zhou, B., Liu, J., Wang, Q., Liu, X. E., Li, X., Li, P., Ma, Q., & Cao, C. (2008) · Journal of Virology · doi:10.1128/jvi.00133-08 · Cited by 104
The history and epidemiology of Middle East respiratory syndrome corona virus
Al-Osail, A. M., & Alwazzeh, M. J. (2017) · Multidisciplinary Respiratory Medicine · doi:10.1186/s40248-017-0101-8 · Cited by 104
Amiodarone Alters Late Endosomes and Inhibits SARS Coronavirus Infection at a Post-Endosomal Level
Stadler, K., Ha, H. R., Ciminale, V., Spirlı̀, C., Saletti, G., Schiavon, M., Bruttomesso, D., Bigler, L., Folláth, F., Pettenazzo, A., et al. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0217oc · Cited by 99
Wang, Y., & Liu, L. (2016) · mBio · doi:10.1128/mbio.01872-15 · Cited by 95
Oligomerization of the carboxyl terminal domain of the human coronavirus 229E nucleocapsid protein
Lo, Y.-S., Lin, S.-Y., Wang, S.-M., Wang, C.-T., Chiu, Y.-L., Huang, T.-H., & Hou, M. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.11.016 · Cited by 94
Roh, C. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s31379 · Cited by 91
Chuck, C. P., Chen, C., Ke, Z., et al. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.10.053 · Cited by 89
Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors
Shimamoto, Y., Hattori, Y., Kobayashi, K., Teruya, K., Sanjoh, A., Nakagawa, A., Yamashita, E., & Akaji, K. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.12.028 · Cited by 81
Recent progress in the discovery of inhibitors targeting coronavirus proteases
Wang, H., Xue, S., Yang, H., & Chen, C. (2016) · Virologica Sinica · doi:10.1007/s12250-015-3711-3 · Cited by 61
Chang, C., Jeyachandran, S., Hu, N., Liu, C.-L., Lin, S.-Y., Wang, Y., Chang, Y.-M., & Hou, M. (2015) · Molecular BioSystems · doi:10.1039/c5mb00582e · Cited by 58
Structural basis for dimerization and RNA binding of avian infectious bronchitis virus nsp9
Hu, T., Chen, C., Li, H., Dou, Y., Zhou, M., Lu, D., Zong, Q., Li, Y., Yang, C., Zhong, Z., et al. (2017) · Protein Science · doi:10.1002/pro.3150 · Cited by 45
Biochemical and cell biological assays to identify and characterize DNA helicase inhibitors
Banerjee, T., Aggarwal, M., Sommers, J. A., & Brosh, R. M. (2016) · Methods · doi:10.1016/j.ymeth.2016.04.007 · Cited by 21
Cited by
Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review
Di Gennaro, F., Pizzol, D., Marotta, C., Antunes, M., Racalbuto, V., Veronese, N., & Smith, L. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17082690 · Cited by 822
Yoshimoto, F. K. (2020) · The Protein Journal · doi:10.1007/s10930-020-09901-4 · Cited by 543
Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic
Gasmi, A., Noor, S., Tippairote, T., Dadar, M., Menzel, A., & Bjørklund, G. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108409 · Cited by 305
Hasan, A., Paray, B. A., Hussain, A., Qadir, F. A., Attar, F., Aziz, F. M., Sharifi, M., Derakhshankhah, H., Rasti, B., Mehrabi, M., et al. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1754293 · Cited by 293
Al-Karmalawy, A. A., Dahab, M. A., Metwaly, A. M., Elhady, S. S., Elkaeed, E. B., Eissa, I. H., & Darwish, K. M. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.661230 · Cited by 286
Metadata
- Authors
- Medhi, B., Prajapat#, M., Sarma#, P., Shekhar#, N., Avti, P., Sinha, S., Kaur, H., Kumar, S., Bhattacharyya, A., Kumar, H., & Bansal, S.
- Venue
- Indian Journal of Pharmacology
- Publisher
- Medknow
- Published
- 2020
- Volume
- 52
- Issue
- 1
- Pages
- 56
- ISSN
- 0253-7613 (ISSN-L)
- OpenAlex
- W3012352458
- Cited by
- 496
- References
- 78
- FWCI
- 6.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.